Sirtex Medical Limited announced an indicated proposal from CDH Investments to acquired Sirtex for $25.15 per share in cash, which is 14.2% higher than its closing price. The acquisition will be totaled up to $1.4 billion. Previously, Varian Medical Systems, Inc., an American radiation oncology treatment provider, has made an acquisition offer at $20.96 per share in January. Although CDH made an offer with higher value, the Directors of Sirtex continue to believe the scheme with Varian is in the best interests of Sertex shareholders. More details....
Stock Symbol: (ASX: SRX)
Share this with colleagues:
Original Article: CDH Investments Proposed to Acquire Sirtex Medical for $1.4 Billion